Registry of Patient With M. Dupuytren and Validation of the Brief MHQ
Launched by SCHULTHESS KLINIK · Jun 10, 2013
Trial Information
Current as of June 14, 2025
Completed
Keywords
ClinConnect Summary
examination of the characteristics of Patient with Morbus Dupuytren and the psychometric properties of the Brief Michigan Hand Questionnaire by this patients
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • M.Dupuytren, over 18y, able to speak and understand german
- Exclusion Criteria:
- • recurrence, pregnancy, incapable of contracting
About Schulthess Klinik
Schulthess Klinik is a renowned medical institution based in Zurich, Switzerland, specializing in orthopedic surgery and rehabilitation. With a commitment to advancing patient care through innovative research and clinical trials, the clinic is dedicated to enhancing treatment outcomes and improving quality of life for individuals with musculoskeletal conditions. Schulthess Klinik combines state-of-the-art technology with a multidisciplinary approach, fostering collaborations among healthcare professionals to ensure comprehensive care and support for patients. Its reputation for excellence in clinical research positions Schulthess Klinik as a leader in the field, contributing valuable insights to the global medical community.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Zurich, , Switzerland
Patients applied
Trial Officials
Daniel Herren, Dr. med.
Study Chair
Schulthess Klinik
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials